United States (HTS) · Section VI
Antisera and other blood fractions
HS 30021200 — Antisera and other blood fractions — sits in Chapter 30 (Pharmaceutical products). Medicaments, vaccines, bandages, dental products, and blood fractions. EU importers pay MFN duty plus import VAT at the border; origin-specific trade remedies (anti-dumping, countervailing, safeguards, US Section 301) can stack on top when applicable. Classification disputes are decided by the section + chapter legal notes shown below — these are legally binding interpretation rules, not advisory text. The duty table renders live rates from authoritative tariff sources (EU TARIC, HMRC XI, USITC HTS); cross-country rows compare treatment under five tariff schedules.
Duty rates (United States (HTS))
- MFN (Most-Favoured-Nation)FreeView source →
- Column 2 (non-NTR)FreeView source →
Rates as published by the destination customs authority. Always confirm with the official tariff before declaring.
Ready to ship under 30021200?
Customs-ready invoice in 2 minutes
No Word template grind, no account, no decisions you don't have to make. The wizard asks the bare minimum and emits a compliant PDF.
How 300212 is treated in other markets
Same 6-digit international HS base, looked up in each authority's published schedule. Click any country to switch the page to that schedule's view.
| Authority | Code published | MFN duty | VAT / GST |
|---|---|---|---|
| United States (HTS)viewing | 30021200 | Free | 0% |
| International (HS 2022) | 300212 | — | — |
| European Union (CN) | 30021200 | Free | 21% |
| United Kingdom | 300212 | — | 20% |
| Israel | 300212 | — | 18% |
Rates compiled from USITC, EU Commission TARIC, HMRC, and Israeli Tax Authority public datasets. Verify with the official tariff before declaring.
Landed cost estimate · United States (HTS)
USD basis- CIF customs valuedeclared$1,000.00
- + DutyFree (MFN duty 0%)$0.00
Full legal rate: Free
- + MPFInformal-entry flat fee ($2.62) — declared value ≤ $2,500$2.62
- + Federal VATNo federal VAT — state / provincial sales tax may apply on resale$0.00
- Total landed cost · United States (HTS)$1,002.62
Likely PGA filings (verify with CBP)
- FDA— Pharmaceuticals + medical devices· FDA Form 2877
- ·Destination has no federal VAT. State / provincial sales tax may still apply at the point of resale.
- ·Likely PGA filings: FDA. Verify with CBP — these are heuristics.
Estimate excludes brokerage fees, freight, insurance, and last-mile delivery. For a binding total, get a quote from a licensed customs broker.
Sibling codes under 300212
Recent news affecting Chapter 30 — Pharmaceutical products
Tariff changes, sanctions, FTAs, and regulatory updates that touch this product class.
Apply for pharma onshoring deals to cut Section 232 duties
The US Department of Commerce opened a 30-day window for pharmaceutical manufacturers to apply for company-specific onshoring agreements under Proclamation 11020. Approved applicants gain eligibility for reduced Section 232 duty rates on imports of their pharma products and ingredients. This targets domestic manufacturing incentives in the pharmaceutical sector.
EU-Canada CETA: Pharma ingredient recognition update
The EU Council adopted Decision 2026/1070 on 5 May 2026, setting the EU's negotiating position within the CETA Joint Committee on how active pharmaceutical ingredients (APIs) are classified and recognized under the mutual GMP (good manufacturing practices) compliance agreement between Canada and the EU. The decision amends Annex 1 to the CETA Protocol on pharmaceutical mutual recognition, clarifying which APIs qualify as medicinal products or drugs under the agreement's scope.
Taiwan optical brighteners: antidumping duty affirmed for 2023–24
The U.S. Department of Commerce has concluded its antidumping administrative review for stilbenic optical brightening agents from Taiwan, covering May 1, 2023 through April 30, 2024. Commerce determined that Teh Fong Min International Co., Ltd. (TFM), the sole producer and exporter under review, sold subject merchandise in the United States at less than normal value. This final determination confirms antidumping duty liability for the review period.
EU–Uzbekistan trade pact: tariff relief and market access
The EU and Uzbekistan have signed an Enhanced Partnership and Cooperation Agreement, effective 29 April 2026. The deal establishes preferential trade terms, removes tariffs on key sectors, and creates a framework for customs cooperation. Shippers moving goods between the EU and Uzbekistan will benefit from reduced duties on eligible products, though origin rules and certificate-of-origin requirements will apply.
Use this code in a customs invoice
Generate a compliant commercial invoice in minutes — no account required.
Open the wizard